bamlanivimab (LY-CoV555) / Eli Lilly, National Institute of Allergy and Infectious Diseases, AbCellera  >>  Phase 1
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl

Download Options